EHR / EMR in California

Beckman Coulter Diagnostics is a global leader in clinical diagnostics and biomedical testing, headquartered in Brea, California. A subsidiary of Danaher Corporation since its foundational 1935 establishment, the company develops, manufactures, and distributes innovative laboratory automation systems, analyzers, and informatics solutions for clinical and research laboratories worldwide. The company specializes in clinical chemistry systems, immunoassay instruments, hematology analyzers, urinalysis systems, microbiology solutions, blood banking instruments, and protein chemistry platforms. Beckman Coulter also provides total lab automation systems (DxA 5000 series), advanced informatics middleware (Remisol Advance), and remote diagnostic services. Its comprehensive portfolio supports healthcare professionals and laboratory teams in disease diagnosis, treatment decisions, patient monitoring, and improved health outcomes. With annual revenue of approximately $2.9 billion, the company emphasizes efficiency, automation, clinical confidence, and integrated workflow solutions for hospital laboratories, reference laboratories, and blood banks globally.

Simple HealthKit is a healthcare infrastructure platform that delivers end-to-end solutions for member engagement, health screening programs, and connected care delivery. The company operates CLIA-certified laboratory infrastructure and provides vertically integrated screening services paired with digital patient engagement tools. Their platform serves health plans, biopharma companies, public health agencies, and retail pharmacy partners. Simple HealthKit specializes in closing HEDIS gaps, improving Star Ratings, and launching preventive care programs rapidly—typically deployable within weeks. The platform combines AI-driven digital-first tools with high-touch, at-home screening programs, supporting enrollment, screening workflows, and longitudinal patient engagement. Their enterprise-ready software integrates with existing health systems and provides real-time analytics, participation tracking, and audit-ready reporting. Clients include major health plans, insurers, retailers (Walmart, Amazon, CVS Pharmacy), state health departments, and public health organizations. The company emphasizes clinical accuracy through CLIA-certified lab operations while maintaining consumer-friendly, accessible healthcare experiences.

CliniComp International is a healthcare IT vendor specializing in integrated electronic health record (EHR) solutions with native artificial intelligence capabilities. The company provides a comprehensive System as a Service (SYaaS) model that bundles software, hardware, implementation services, training, ongoing support, and continuous optimization into a single transparent contract. CliniComp's New Era EHR Solution Suite covers inpatient, ambulatory, ancillary operations, and revenue cycle management (RCM) within a single unified platform. The system features native AI embedded throughout clinical workflows, real-time advanced analytics, and comprehensive medical device integration that automates data capture from hundreds of bedside devices directly into patient records. Key differentiators include: (1) true interoperability built into core architecture for longitudinal patient records; (2) all integration and services included upfront with no hidden costs; (3) rapid implementation achievable in months rather than years; (4) proven reliability with decades of continuous operation, including documented zero-downtime records exceeding 25 years at some facilities. CliniComp serves health systems of all sizes, including Veterans Affairs facilities, rural hospitals, and large academic medical centers. The company emphasizes reducing clinician administrative burden, improving care coordination, enhancing patient safety, and delivering measurable ROI. CliniComp has received industry recognition including the 2025 MedTech Breakthrough Award, Healthcare Technology Review Top 50 award, and the 2026 Trailblazer in Healthcare Technology Pinnacle Award for its SYaaS model innovation.

eHealth Technologies is an AI-based healthcare interoperability platform company with over 20 years of healthcare experience. The company develops and operates eHealth Connect®, a proprietary platform that streamlines the collection, clinical organization, and delivery of patient medical records—including imaging and pathology data—to health systems, care coordination companies, life sciences organizations, and Health Information Exchanges (HIEs). The platform addresses a critical gap in healthcare delivery by automating the gathering and clinical organization of comprehensive patient histories in a disease-specific manner, reducing time-to-treatment, clinician administrative burden, and overhead costs while improving patient outcomes and provider revenue. The solution integrates directly into electronic health record (EHR) workflows, enabling clinicians to access complete, actionable medical histories at the point of care. eHealth Technologies serves top-tier U.S. healthcare institutions and has been recognized by Newsweek as one of the World's Best Digital Health Companies. The platform reportedly delivers millions of medical records annually across thousands of healthcare locations, supporting faster appointment scheduling, reduced clinician burnout, and improved care coordination across fragmented healthcare systems.

Glooko is a digital health platform specializing in diabetes management and glycemic control. The company operates two primary product lines: the outpatient Glooko Diabetes Management Platform and the inpatient EndoTool Glucose Management System (acquired via Monarch Medical Technologies). The outpatient platform integrates data from over 200 diabetes and health monitoring devices, providing seamless connectivity with continuous glucose monitors (CGMs), blood glucose meters, and wearables. It enables remote patient monitoring, population health management, and secure remote collaboration between patients and care teams through the Glooko Mobile App and clinic dashboard. EndoTool is a patient-specific insulin dosing system designed for hospital inpatient glycemic management, with clinical data showing virtual elimination of severe hypoglycemia. Glooko serves 8,000+ clinics across 30+ countries, providing actionable insights to streamline clinical workflows and improve diabetes outcomes. Clinical evidence demonstrates 18% reduction in average blood glucose within three months and sustained HbA1c improvements. The company maintains robust security and privacy compliance including HITRUST, HIPAA, SOC 2 Type II, ISO 27001, and GDPR certifications, ensuring enterprise-grade data protection for patient health information. Glooko's platform is built on device connectivity standards and interoperability principles to eliminate fragmented data across healthcare systems. The company targets hospitals, health systems, clinics, and individual patients requiring comprehensive diabetes data management and remote monitoring capabilities.

Athelas is a healthcare software company providing an integrated platform for revenue cycle management (RCM), electronic health records (EHR), and AI-powered clinical documentation. The company offers four primary products: (1) Athelas RCM (formerly RCM Insights), an AI-driven platform for claim management, denial defense, and revenue optimization through automated claim processing and predictive analytics; (2) Ambient AI, an intelligent medical scribe and copilot system that automatically generates clinical notes, CPT/ICD-10 codes, and compliance checks with real-time EMR integration; (3) Athelas Air, a modern EHR designed for ambulatory practices with features including AI-powered patient intake, autonomous receptionist, patient portal, pre-visit workflows, and integrated documentation; and (4) Athelas Agents, customizable AI assistants for scheduling, insurance authorizations, appeals, and data retrieval from external systems. The platform serves diverse healthcare organizations including urgent care, physical therapy, orthopedics, dermatology, ENT, and specialty practices. Key capabilities include automated remittance reconciliation, AI-powered portal data extraction, revenue analytics dashboards, parallel scribing for overlapping patient encounters, compliance nudges, and autonomous patient engagement. Customers report measurable outcomes including improved first-pass claim rates (95%+), increased collections ($17–$3.6M monthly), reduced denial rates (1–1.5%), and significant time savings (2+ hours per provider daily). The company emphasizes security, customization, and seamless EHR integration across major platforms.

RadiusXR is a healthcare technology company specializing in portable, wearable vision diagnostics and patient engagement systems for ophthalmology and optometry practices. Founded in 2017, RadiusXR develops advanced XR (extended reality) headsets paired with a customized software platform for self-guided, clinically validated vision testing. The core offerings include RadiusExam® software for comprehensive vision field assessments and Inspire® for detecting ophthalmic diseases such as glaucoma. The fully integrated digital vision solution features cloud-connected technology, EHR integration, built-in business management tools, and patient education libraries. The platform enables visual field testing in traditional clinical settings as well as primary care, remote, and at-home environments. RadiusXR's technology is clinically validated with peer-reviewed publications and has received industry recognition including Fast Company's Most Innovative Companies of 2024. Strategic partnerships with Glaukos Corporation and Topcon Healthcare expand distribution and clinical integration.

QT Medical, Inc. is a medical device manufacturer specializing in portable, wireless, cloud-connected 12-lead ECG systems for hospital-grade cardiac diagnostics and monitoring. Founded in 2013 and based in Diamond Bar, California, the company provides FDA-cleared solutions for both home-use self-monitoring and professional acute care settings. The QT ECG / PCA 500™ platform features pre-positioned sensors (QHeart®), AI-driven computer interpretation, and HIPAA-compliant cloud storage (ECGcloud®). Products are designed for patients from newborns to adults, reducing lead placement time by up to 70% and minimizing common errors such as limb-lead reversal. The company offers integrated mobile applications (iOS, Android, Windows) and cloud-based workflow management. QT Medical also provides Xpress ECG home delivery services and telemedicine-compatible solutions to enable accessible cardiac care across clinical and home environments.

SOTA Cloud is a cloud-based dental imaging software platform that integrates diagnostic imaging, practice management, and clinical collaboration tools. Founded as a spinoff from SOTA Imaging in 2021, the company provides FDA-cleared imaging and diagnostic solutions including AI oral disease detection (Pearl), CBCT imaging with multiplanar reconstruction, and support for 3D intraoral scans. The platform integrates seamlessly with virtually all intraoral sensors, panoramic/cephalometric machines, and 20+ practice management systems (e.g., CareStack, Eaglesoft, Apertyx). Key features include browser-based image capture and viewing with unlimited cloud storage, AI-powered referral letter generation, secure file sharing with built-in DICOM dataset attachment, and comprehensive practice analytics for exam tracking, staff performance, and device monitoring. SOTA Cloud serves independent practices, group practices, dental service organizations (DSOs), and educational institutions, with emphasis on vendor independence, compliance, and multi-location workflow automation.

Q Bio operates a preventive health clinic offering comprehensive diagnostic assessment and longitudinal health monitoring through an integrated platform combining MRI imaging, EKG, biometric measurement, genetic analysis, and wearable data integration. The company has developed a proprietary digital health platform that creates a 3D digital twin of patient biology, presenting nine biological subsystems through an interactive dashboard. The Q Exam, conducted at their Redwood City, California clinic, is a 75-minute comprehensive assessment that includes full-body MRI, ECG/EKG, biometric and vital signs collection, genetic measurements, and integration of wearable device data. The platform delivers AI-assisted analytics to support clinical decision-making and trend analysis from longitudinal patient data. Q Bio positions itself as a platform provider for clinics and longevity-focused partners seeking to offer preventive health services beyond standard physical examinations. The company has deployed its system at its own clinic and reports successful integration at other major longevity partners. The team comprises PhDs, MScs, and MDs from world-class institutions. The service model includes concierge scheduling, fast results delivery via personalized health dashboard, and post-exam consultation with Q Bio physicians. The platform is designed to be embedded into existing clinic workflows and integrated health stacks.

Planet DDS is a cloud-based dental software provider headquartered in Irvine, California, serving over 13,000 dental practices across North America with a user base exceeding 60,000. Founded in 2003, the company specializes in scalable enterprise solutions for dental support organizations (DSOs), dental groups, and multi-location practices through its proprietary DentalOS™ operating system. The platform comprises integrated modules: Denticon (practice management), Cloud 9 (orthodontic-specific PM), Apteryx (cloud-based 2D/3D dental imaging with AI), Planet DDS Pay (integrated payment processing), and MyTooth (patient engagement). Solutions address core operational needs including appointment scheduling, digital imaging management, patient communication, integrated payments, revenue cycle management, and clinical documentation with AI-powered voice charting. The company targets DSOs and enterprise dental organizations seeking cloud infrastructure to reduce IT overhead, improve HIPAA compliance, and achieve operational efficiency and scalability.

Invivoscribe is a San Diego-based molecular diagnostics company founded in 1995, specializing in precision oncology testing and personalized molecular medicine for hematologic malignancies. The company develops and manufactures CE-marked in vitro diagnostic assays, research-use-only (RUO) assays, analyte-specific reagents (ASRs), and DNA/RNA controls under ISO 13485 design control. Core product lines include next-generation sequencing (NGS) panels for clonality testing (B- and T-cell), minimal residual disease (MRD) assays (LymphTrack®, LeukoStrat® FLT3-ITD and NPM1), and companion diagnostics (CDx) for precision oncology drug therapies. Invivoscribe operates LabPMM®, a CAP-accredited clinical laboratory with multiparametric flow cytometry and molecular testing services, serving clinical laboratories, pharmaceutical companies, and researchers across 160+ countries and 700+ laboratories worldwide. The company also provides bioinformatics software, custom assay development, and turn-key CDx collaboration for pharmaceutical partners, emphasizing regulatory expertise and streamlined drug approval pathways.

ReNovo Solutions is a healthcare and life sciences asset management company founded in 2009, specializing in clinical equipment and technology lifecycle management for hospitals, health systems, and research facilities across the United States. The company provides vendor-neutral clinical asset management, biomedical engineering services, cybersecurity risk mitigation, and IT operations support through its proprietary RENOVOLive® CMMS platform. ReNovo's service portfolio includes clinical engineering staffing, capital equipment planning and consulting, lab asset management, lab operations and compliance support, and laboratory relocation services. The company has managed over 2.1 million assets and maintains a 23.4% client retention rate, demonstrating deep expertise in reducing equipment lifecycle costs by 10-20% while improving operational efficiency and patient care delivery.

AgileMD is a clinical decision support software company providing FDA-cleared AI and workflow integration solutions for hospital systems. The platform consists of two primary product lines: eCART™, an FDA-cleared clinical deterioration early warning system that uses machine learning to predict patient risk and guide ICU transfer decisions, and Clinical Pathways, a highly integrated guidance system that standardizes clinical protocols and reduces variation across care settings. eCART leverages nearly 3 million patient encounters from 28 hospitals across 6 health systems for training and validation, with peer-reviewed publications demonstrating reduced mortality, decreased length of stay, and lower direct variable costs. Clinical Pathways enable rapid deployment of evidence-based protocols directly into EHR workflows without extensive IT support, covering 4,800+ active pathways across adult, pediatric, and neonatal settings in ambulatory, emergency, inpatient, ICU, and women's health domains. The platform is SOC-II and HIPAA compliant, operates as a cloud-based hosted service requiring no on-site hardware, and serves 400+ hospitals with 150,000+ clinical users across 4.4+ million patient encounters. AgileMD's solutions focus on reducing clinical burden, standardizing care delivery, and enabling real-time clinical decision support embedded seamlessly within existing EHR workflows.

ResMed is a global digital health and cloud-connected medical devices company specializing in sleep health, respiratory care, and hospital management solutions. The company manufactures CPAP machines, masks, and accessories for obstructive sleep apnea treatment; non-invasive ventilators (Astral, Stellar) for COPD, neuromuscular disease, and pediatric patients; and home sleep testing diagnostics equipment (NightOwl, ApneaLink Air). ResMed distributes across Americas, Europe, Asia Pacific, Africa, and Middle East. Product lines include sleep apnea therapy devices, respiratory ventilation systems, CPAP masks and supplies, and replacement parts. The company offers digital health platforms including AirView (remote device monitoring), myAir (patient engagement app), and Propeller Health for chronic disease management. ResMed also provides EHR and business management software through acquisitions: Brightree, MatrixCare, CitusHealth (residential care), and Somnoware (sleep lab management). Clinical education, training resources, and reimbursement support are available through ResMed Academy Online and professional channels. The company maintains global regulatory compliance and markets products to hospitals, sleep clinics, home medical equipment providers (HMEs), physicians, and patients.